# Neonatal SARS-CoV-2 Anti-spike Protein Receptor-binding Domain Antibodies at Delivery

> **NCT05564884** · — · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 58 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **OTHER:** no intervantion

## Key facts

- **NCT ID:** NCT05564884
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-12
- **Primary completion:** 2022-02-24
- **Final completion:** 2022-11-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05564884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05564884, "Neonatal SARS-CoV-2 Anti-spike Protein Receptor-binding Domain Antibodies at Delivery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05564884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*